Literature DB >> 204321

Extraction of CEA from tumour tissue, foetal colon and patients' sera, and the effect of perchloric acid.

P A Keep, B A Leake, G T Rogers.   

Abstract

The use of perchloric acid and water for the extraction of CEA from tumour and foetal tissues has been investigated. In the case of tumour, lower recoveries of CEA were obtained from perchloric acid extracts than from aqueous extracts of the same tissue. CEA has also been extracted with 3M KCl solution from insoluble perchloric acid residues of tumour homogenates and cancer patients' serum. Whilst a large proportion of CEA activity recovered from tumour was associated with the perchloric acid residue, the corresponding amounts from serum were very small. CEA elution volumes for each extract, obtained by assay of Sephadex G-200 column fractions, showed significant heterogeneity in molecular size. The purified CEA pools also showed quantitative variations in the binding profiles on Con A-Sepharose. It has been shown that perchloric acid modifies the carbohydrate in CEA, thus altering its Con A-binding properties. Preliminary experiments with foetal colon have demonstrated that, unlike colorectal CEA, a significant proportion of foetal CEA was not bound to ConA. Comparative immunodiffusion showed immunological identity of CEA from the various extracts, although the purified aqueous extract produced an additional precipitin reaction, indicating a second antigen which is relatively unstable or less soluble in perchloric acid.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 204321      PMCID: PMC2009599          DOI: 10.1038/bjc.1978.25

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  24 in total

1.  Purification of carcinoembryonic antigen by removal of contaminating mucopolysaccharides.

Authors:  D G Pritchard; C W Todd
Journal:  Cancer Res       Date:  1976-12       Impact factor: 12.701

Review 2.  Heterogeneity of carcinoembryonic antigen. Implications on its role as a tumour marker substance.

Authors:  G T Rogers
Journal:  Biochim Biophys Acta       Date:  1976-12-23

3.  Brief communication: carcinoembryonic antigen in colon cancer: absence in perchloric acid precipitates of plasma.

Authors:  J J Sorokin; H Z Kupchik; N Zamcheck
Journal:  J Natl Cancer Inst       Date:  1973-09       Impact factor: 13.506

4.  The specificity of carcino-foetal antigens of the human digestive-tract tumours.

Authors:  F Martin; M S Martin; M Bordes; C Bourgeaux
Journal:  Eur J Cancer       Date:  1972-06       Impact factor: 9.162

5.  Heterogeneity of carcinoembryonic antigen and its fractionation by con A affinity chromatography.

Authors:  G T Rogers; F Searle; K D Bagshawe
Journal:  Nature       Date:  1974-10-11       Impact factor: 49.962

6.  Heterogeneity and specificity of circulating carcinoembryonic antigen.

Authors:  G T Rogers; B A Leake; F Searle; K D Bagshawe
Journal:  Eur J Cancer       Date:  1977-03-29       Impact factor: 9.162

7.  Carcinoembryonic antigen in serum in diseases of the liver and pancreas.

Authors:  S K Khoo; I R Mackay
Journal:  J Clin Pathol       Date:  1973-07       Impact factor: 3.411

8.  Comparison of whole plasma and perchloric acid-extracted plasma assays for carcinoembryonic antigen.

Authors:  L K Ashman; J Ludbrook; V R Marshall
Journal:  Clin Chim Acta       Date:  1977-01-03       Impact factor: 3.786

9.  Carcinoembryonic antigen (CEA) in non digestive cancerous and normal tissues.

Authors:  G Pusztaszeri; J P Mach
Journal:  Immunochemistry       Date:  1973-03

10.  DEMONSTRATION OF TUMOR-SPECIFIC ANTIGENS IN HUMAN COLONIC CARCINOMATA BY IMMUNOLOGICAL TOLERANCE AND ABSORPTION TECHNIQUES.

Authors:  P GOLD; S O FREEDMAN
Journal:  J Exp Med       Date:  1965-03-01       Impact factor: 14.307

View more
  8 in total

1.  Effective production of carcinoembryonic antigen by conversion of the membrane-bound into a recombinant secretory protein by site-specific mutagenesis.

Authors:  Fakhraddin Naghibalhossaini; Abbas Pakdel; Abbas Ali Ghaderi; Mehdi Saberi Firoozi
Journal:  Pathol Oncol Res       Date:  2005-12-31       Impact factor: 3.201

2.  An approach to the routine estimation of circulating carcinoembryonic antigen immune complexes in patients with carcinomata of the gastrointestinal tract.

Authors:  K Kapsopoulou-Dominos; F A Anderer
Journal:  Clin Exp Immunol       Date:  1979-07       Impact factor: 4.330

3.  Serum CEA in the follow-up of colorectal carcinoma: experience in a district general hospital.

Authors:  T G Allen-Mersh
Journal:  Ann R Coll Surg Engl       Date:  1984-01       Impact factor: 1.891

4.  Preoperative carcinoembryonic antigen levels correlated with postoperative pathological staging in bronchial carcinoma.

Authors:  J F Paone; A Kardana; G T Rogers; J Dhasmana; K Jeyasingham
Journal:  Thorax       Date:  1980-12       Impact factor: 9.139

5.  Circulating immune complexes (CIC), carcinoembryonic antigen (CEA) and CIC containing CEA as markers for colorectal cancer.

Authors:  K A Chester; R H Begent
Journal:  Clin Exp Immunol       Date:  1984-12       Impact factor: 4.330

6.  Relationship of serum CEA levels to tumour size and CEA content in nude mice bearing colonic-tumour xenografts.

Authors:  J C Lewis; P A Keep
Journal:  Br J Cancer       Date:  1981-09       Impact factor: 7.640

7.  Somatic-cell hybrids producing antibodies against CEA.

Authors:  G T Rogers; G A Rawlins; K D Bagshawe
Journal:  Br J Cancer       Date:  1981-01       Impact factor: 7.640

8.  The CEA Second-Look Trial: a randomised controlled trial of carcinoembryonic antigen prompted reoperation for recurrent colorectal cancer.

Authors:  Tom Treasure; Kathryn Monson; Francesca Fiorentino; Christopher Russell
Journal:  BMJ Open       Date:  2014-05-13       Impact factor: 2.692

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.